172 related articles for article (PubMed ID: 19933947)
21. More Considerations for Risk Stratification of Fetal Atrioventricular Block Beyond Anti-Ro Titer: comment on the article by Buyon et al.
Kao JH; Su CF
Arthritis Rheumatol; 2024 Jun; 76(6):985-986. PubMed ID: 38233971
[No Abstract] [Full Text] [Related]
22. Diagnosing foetal atrioventricular heart blocks.
Sonesson SE
Scand J Immunol; 2010 Sep; 72(3):205-12. PubMed ID: 20696017
[TBL] [Abstract][Full Text] [Related]
23. Prenatal heart block screening in mothers with SSA/SSB autoantibodies: Targeted screening protocol is a cost-effective strategy.
Evers PD; Alsaied T; Anderson JB; Cnota JF; Divanovic AA
Congenit Heart Dis; 2019 Mar; 14(2):221-229. PubMed ID: 30444309
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous Remission of Congenital Complete Atrioventricular Block in Anti-Ro/La Antibody-Negative Monozygotic Twins: Case Report.
Kasar T; Saygı M; Özyılmaz İ; Ergül Y
Balkan Med J; 2017 Jan; 34(1):71-73. PubMed ID: 28251027
[TBL] [Abstract][Full Text] [Related]
25. [Fetal atrioventricular interval measurement: technical aspects].
Journet D; Bienstman J; Joly H; Rudigoz RC; Huissoud C
J Gynecol Obstet Biol Reprod (Paris); 2011 Oct; 40(6):580-5. PubMed ID: 21880439
[TBL] [Abstract][Full Text] [Related]
26. Fetus with heart failure due to congenital atrioventricular block treated by maternally administered ritodrine.
Matsubara S; Morimatsu Y; Shiraishi H; Kuwata T; Ohkuchi A; Izumi A; Takeda S; Suzuki M
Arch Gynecol Obstet; 2008 Jul; 278(1):85-8. PubMed ID: 18066569
[TBL] [Abstract][Full Text] [Related]
27. Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen.
Tran HB; Cavill D; Buyon JP; Gordon TP
Arthritis Rheum; 2004 Jan; 50(1):337-8; author reply 338. PubMed ID: 14730639
[No Abstract] [Full Text] [Related]
28. Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature.
Breur JM; Visser GH; Kruize AA; Stoutenbeek P; Meijboom EJ
Ultrasound Obstet Gynecol; 2004 Sep; 24(4):467-72. PubMed ID: 15343606
[TBL] [Abstract][Full Text] [Related]
29. Fetal magnetocardiography (fMCG) to monitor cardiac time intervals in fetuses at risk for isoimmune AV block.
Kiefer-Schmidt I; Lim M; Preissl H; Draganova R; Weiss M; Abele H; Kagan KO; Henes J
Lupus; 2014 Aug; 23(9):919-25. PubMed ID: 24639473
[TBL] [Abstract][Full Text] [Related]
30. Predictive markers and prenatal management of isolated fetal complete atrioventricular block: A retrospective review at a single institution.
Murakami K; Yamamoto Y; Fukunaga H; Matsushita M; Hirai C; Makino S; Shimizu T; Itakura A; Takeda S
J Obstet Gynaecol Res; 2018 Feb; 44(2):228-233. PubMed ID: 29160028
[TBL] [Abstract][Full Text] [Related]
31. Specificity and effector mechanisms of autoantibodies in congenital heart block.
Wahren-Herlenius M; Sonesson SE
Curr Opin Immunol; 2006 Dec; 18(6):690-6. PubMed ID: 17011766
[TBL] [Abstract][Full Text] [Related]
32. Progressive disease of the atrioventricular conduction axis in an infant of an anti-Ro positive mother.
Uzun O; Gibbs JL
Cardiol Young; 1999 Mar; 9(2):192-3. PubMed ID: 10323519
[TBL] [Abstract][Full Text] [Related]
33. Controversies in the Management of Isolated Congenital Atrioventricular Block.
DeNoble AE; Kuller JA; Rhee EJ
Obstet Gynecol Surv; 2015 Aug; 70(8):518-23. PubMed ID: 26314237
[TBL] [Abstract][Full Text] [Related]
34. [Fetal myocarditis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block with good outcome].
De La Villeon CG; Dulac Y; Ohanessian G; Ziani A; Paranon S; Acar P
Arch Pediatr; 2010 Oct; 17(10):1445-7. PubMed ID: 20541376
[TBL] [Abstract][Full Text] [Related]
35. [Neonatal lupus revisited].
Meyer O
Ann Dermatol Venereol; 2008; 135(8-9):596-600. PubMed ID: 18789297
[No Abstract] [Full Text] [Related]
36. Serologic follow-up of children born to mothers with Ro/SSA autoantibodies.
Klauninger R; Skog A; Horvath L; Winqvist O; Edner A; Bremme K; Sonesson SE; Wahren-Herlenius M
Lupus; 2009 Aug; 18(9):792-8. PubMed ID: 19578103
[TBL] [Abstract][Full Text] [Related]
37. Juvenile-onset hypergammaglobulinemic purpura and fetal congenital heart block.
Maeda-Tanaka M; Haruta S; Sado T; Uchida Y; Takahashi Y; Asada H; Miyagawa S
J Dermatol; 2006 Oct; 33(10):714-8. PubMed ID: 17040503
[TBL] [Abstract][Full Text] [Related]
38. Letter by Jaeggi et al regarding article, "Perinatal outcome of fetal atrioventricular block: one-hundred sixteen cases from a single institution".
Jaeggi ET; Golding F; Silverman ED
Circulation; 2009 May; 119(20):e539; author reply e541-2. PubMed ID: 19470895
[No Abstract] [Full Text] [Related]
39. Prevention of congenital heart block in children of SSA-positive mothers.
Brucato A
Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii35-7. PubMed ID: 18504284
[TBL] [Abstract][Full Text] [Related]
40. Fetal first-degree heart block, or where to set the confidence limit: comment on the article by Sonesson et al.
Rein AJ; Mevorach D; Perles Z; Shovali A; Elchalal U
Arthritis Rheum; 2005 Jan; 52(1):366; author reply 366-8. PubMed ID: 15641053
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
